453 related articles for article (PubMed ID: 26196392)
41. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
Hui CM; Cheung PY; Ling MT; Tsao SW; Wang X; Wong YC; Cheung AL
Int J Cancer; 2006 Aug; 119(3):508-14. PubMed ID: 16506209
[TBL] [Abstract][Full Text] [Related]
42. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.
Gwak H; Kim Y; An H; Dhanasekaran DN; Song YS
Mol Carcinog; 2017 Feb; 56(2):349-358. PubMed ID: 27128966
[TBL] [Abstract][Full Text] [Related]
43. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.
Liu J; Li M; Song B; Jia C; Zhang L; Bai X; Hu W
Urol Oncol; 2013 Feb; 31(2):264-70. PubMed ID: 21676631
[TBL] [Abstract][Full Text] [Related]
44. Exogenous activation of LKB1/AMPK signaling induces G₁ arrest in cells with endogenous LKB1 expression.
Liang X; Wang P; Gao Q; Tao X
Mol Med Rep; 2014 Mar; 9(3):1019-24. PubMed ID: 24469340
[TBL] [Abstract][Full Text] [Related]
45. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
46. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
[TBL] [Abstract][Full Text] [Related]
47. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.
Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J
Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980
[TBL] [Abstract][Full Text] [Related]
48. Halofuginone and artemisinin synergistically arrest cancer cells at the G1/G0 phase by upregulating p21Cip1 and p27Kip1.
Chen G; Gong R; Shi X; Yang D; Zhang G; Lu A; Yue J; Bian Z
Oncotarget; 2016 Aug; 7(31):50302-50314. PubMed ID: 27385212
[TBL] [Abstract][Full Text] [Related]
49. Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma.
Wang J; Liu Z; Wang Z; Wang S; Chen Z; Li Z; Zhang M; Zou J; Dong B; Gao J; Shen L
Cancer Lett; 2018 Apr; 419():64-74. PubMed ID: 29366803
[TBL] [Abstract][Full Text] [Related]
50. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
[TBL] [Abstract][Full Text] [Related]
51. Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest.
Zhou X; Kuang Y; Liang S; Wang L
J Pharmacol Sci; 2019 Dec; 141(4):146-152. PubMed ID: 31744691
[TBL] [Abstract][Full Text] [Related]
52. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
53. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.
Sha B; Sun Y; Zhao S; Li M; Huang W; Li Z; Shi J; Han X; Li P; Hu T; Chen P
Cell Biol Toxicol; 2023 Oct; 39(5):2011-2032. PubMed ID: 35022897
[TBL] [Abstract][Full Text] [Related]
54. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
55. [Expression of cell cycle related proteins cyclin D1, p53 and p21WAF1/Cip1 in esophageal squamous cell carcinoma].
Lin DC; Shi ZZ; Xue LY; Chen W; Xu X; Han YL; Lv N; Wang MR
Yi Chuan; 2010 May; 32(5):455-60. PubMed ID: 20466633
[TBL] [Abstract][Full Text] [Related]
56. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1.
Shen G; Xu C; Chen C; Hebbar V; Kong AN
Cancer Chemother Pharmacol; 2006 Feb; 57(3):317-27. PubMed ID: 16170570
[TBL] [Abstract][Full Text] [Related]
57. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo.
Zhu L; Luo Q; Bi J; Ding J; Ge S; Chen F
Chem Biol Interact; 2014 Dec; 224():149-56. PubMed ID: 25450235
[TBL] [Abstract][Full Text] [Related]
58. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
[TBL] [Abstract][Full Text] [Related]
59. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X
Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688
[TBL] [Abstract][Full Text] [Related]
60. Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines.
Fukuoka S; Kojima T; Koga Y; Yamauchi M; Komatsu M; Komatsuzaki R; Sasaki H; Yasunaga M; Matsumura Y; Doi T; Ohtsu A
Oncotarget; 2017 Feb; 8(7):11020-11029. PubMed ID: 28038457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
